Published in J Card Fail on May 01, 2007
The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol (2004) 4.55
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation (2004) 3.05
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol (2005) 2.47
Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation (2006) 2.11
Cardiorenal syndrome: new perspectives. Circulation (2010) 2.03
Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation (2002) 1.74
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail (2008) 1.66
Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J (2006) 1.62
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
Exploration of patients' readiness for an eHealth management program for chronic heart failure: a preliminary study. J Cardiovasc Nurs (2008) 1.44
Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol (2013) 1.42
Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. JACC Cardiovasc Imaging (2008) 1.29
Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia. Am J Cardiol (2006) 1.23
B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J (2006) 1.20
MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol (2011) 1.18
Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin (2011) 1.17
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. Circulation (2007) 1.10
Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun (2010) 1.06
Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. J Am Coll Cardiol (2009) 1.05
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. J Am Coll Cardiol (2005) 1.03
Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep (2011) 0.98
Three-dimensional contrast-enhanced multidetector CT for anatomic, dynamic, and perfusion characterization of abnormal myocardium to guide ventricular tachycardia ablations. Circ Arrhythm Electrophysiol (2010) 0.96
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. PLoS One (2012) 0.94
Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality. Clin Transl Sci (2011) 0.94
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. Health Serv Res (2013) 0.93
The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am J Med (2007) 0.92
Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation (2002) 0.92
Importance and management of chronic sleep apnoea in cardiology. Eur Heart J (2012) 0.91
Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathog (2013) 0.90
Clinical application of PET/CT fusion imaging for three-dimensional myocardial scar and left ventricular anatomy during ventricular tachycardia ablation. J Cardiovasc Electrophysiol (2009) 0.90
Yersinia pseudotuberculosis uses Ail and YadA to circumvent neutrophils by directing Yop translocation during lung infection. Cell Microbiol (2013) 0.89
Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study. Am J Cardiol (2005) 0.88
Impact of ICD artifact burden on late gadolinium enhancement cardiac MR imaging in patients undergoing ventricular tachycardia ablation. Pacing Clin Electrophysiol (2014) 0.86
New York Heart Association functional class predicts exercise parameters in the current era. Am Heart J (2009) 0.86
Association between depressive symptoms and fibrosis markers: the Cardiovascular Health Study. Brain Behav Immun (2009) 0.86
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail (2012) 0.84
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol (2007) 0.83
Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung (2008) 0.83
Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study. Clin Transl Sci (2010) 0.83
A multicenter study of shock pathways for subcutaneous implantable defibrillators. J Cardiovasc Electrophysiol (2013) 0.83
Prognostic indicators: useful for clinical care? J Am Coll Cardiol (2009) 0.82
Assessment of ventricular tachycardia scar substrate by intracardiac echocardiography. Pacing Clin Electrophysiol (2013) 0.80
Diuretics: are our ideas based on knowledge? J Am Coll Cardiol (2011) 0.79
Diuretics: still the mainstay of treatment. Crit Care Med (2008) 0.79
Sex, digitalis, and the sodium pump. Mol Interv (2003) 0.79
Acute congestive heart failure in the emergency department. Cardiol Clin (2006) 0.79
Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2002) 0.78
Legume seed exudates and Physcomitrella patens extracts influence swarming behavior in Rhizobium leguminosarum. Can J Microbiol (2013) 0.78
The neurohormonal paradigm: have we gone too far? J Am Coll Cardiol (2003) 0.78
Perioperative beta-blockade: a survey of physician attitudes in the department of Veterans Affairs. J Cardiothorac Vasc Anesth (2004) 0.78
Impedance cardiography: more questions than answers. Curr Heart Fail Rep (2006) 0.78
Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis. J Card Fail (2004) 0.77
Robust gene expression with amplified RNA from biopsy-sized human heart tissue. J Mol Cell Cardiol (2006) 0.76
The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. Am J Geriatr Pharmacother (2012) 0.76
Childhood asthma: a guide for pediatric emergency medicine providers. Emerg Med Clin North Am (2013) 0.76
Differences in quantitative assessment of myocardial scar and gray zone by LGE-CMR imaging using established gray zone protocols. Int J Cardiovasc Imaging (2014) 0.76
Implantable cardioverter-defibrillator therapy after myocardial infarction. N Engl J Med (2005) 0.75
Cardiac resynchronization therapy for heart failure. N Engl J Med (2002) 0.75
Enhanced external counterpulsation: what can we learn from the treatment of neurasthenia? J Am Coll Cardiol (2006) 0.75
Using and misusing statistics: what do we know about the effects of race on the impact of β-blockers? Circ Heart Fail (2012) 0.75
The impact of finally publishing a negative study: new conclusions about endothelin antagonists. J Card Fail (2005) 0.75
Defibrillation testing unplugged. Heart Rhythm (2013) 0.75
Impedance cardiography: more questions than answers. Curr Cardiol Rep (2006) 0.75
Impact of fluoroscopy unit on the accuracy of a magnet-based electroanatomic mapping and navigation system: an in vitro and in vivo validation study. Pacing Clin Electrophysiol (2013) 0.75
Pacemaker/implantable cardioverter-defibrillator interaction. Heart Rhythm (2010) 0.75
Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction. Curr Heart Fail Rep (2004) 0.75
High-frequency vagal stimulation: pacing fast to slow down. Heart Rhythm (2010) 0.75
Preface: depression and heart failure. Heart Fail Clin (2011) 0.75
Acute decompensated heart failure. Cardiol Clin (2012) 0.75